Page last updated: 2024-10-28

hydroxyzine and Chronic Kidney Diseases

hydroxyzine has been researched along with Chronic Kidney Diseases in 1 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"In total, 3252 Chronic Renal Insufficiency Cohort participants with at least one study electrocardiogram between 2003 and 2011 were included."1.46Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. ( Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Snitker, S1
Doerfler, RM1
Soliman, EZ1
Deo, R1
St Peter, WL1
Kramlik, S1
Fischer, MJ1
Navaneethan, S1
Delafontaine, P1
Jaar, BG1
Ojo, A1
Makos, GK1
Slaven, A1
Weir, MR1
Zhan, M1
Fink, JC1

Other Studies

1 other study available for hydroxyzine and Chronic Kidney Diseases

ArticleYear
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, 09-07, Volume: 12, Issue:9

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diab

2017